Introducing the Atropos Evidence™ Agent–seamlessly integrating RWE into the clinical workflow.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
  • Technology
        • Platform
          • GENEVA OS®
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button®
          • Alexandria®
          • Forge®
          • Atropos Evidence™ Agent
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Atropos Health Named to Time’s The Best Inventions of 2025

Atropos Health Named to Time’s The Best Inventions of 2025

by Julia Rudo | Oct 9, 2025 | News and Media

ChatRWD®, the generative artificial intelligence (AI) platform from Atropos Health, was named to Time Magazine’s The Best Inventions of 2025. ChatRWD generates actionable insights for providers at the point of care, particularly for underserved populations...
Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems

Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems

by Julia Rudo | Jun 10, 2025 | Cell Case Study, Publications

A manuscript titled, “Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems,” was published in Digital Health by authors affiliated with Atropos Health, Stanford University, The Hospital for Sick...
CEO and Co-founder Dr. Brigham Hyde Joins Mark Niu on CGTN America to discuss AI in Healthcare and Atropos Health’s ChatRWD®

CEO and Co-founder Dr. Brigham Hyde Joins Mark Niu on CGTN America to discuss AI in Healthcare and Atropos Health’s ChatRWD®

by Julia Rudo | Apr 22, 2025 | News and Media, Video

The use of artificial intelligence (AI) in healthcare is increasingly more common and its capabilities are growing. In this video, Dr. Brigham Hyde, CEO and Co-founder of Atropos Health, joins Mark Niu of CGTN America to discuss ChatRWD®, the first generative AI...
Emory Healthcare selects Atropos Health to generate real-world evidence with new tool

Emory Healthcare selects Atropos Health to generate real-world evidence with new tool

by Julia Rudo | Mar 13, 2025 | News and Media

“Academic health system Emory Healthcare has selected Atropos Health to implement a new decision-making tool for generating evidence from real-world data (RWD) for clinicians. The tool is designed to enhance patient outcomes and reduce healthcare costs. It aims to...
Atropos Health’s SVP Joy Somogyi Named as Top Leader in Healthcare Technology of 2024

Atropos Health’s SVP Joy Somogyi Named as Top Leader in Healthcare Technology of 2024

by Joy Somogyi | Feb 9, 2025 | News and Media

On February 5, 2025, The Healthcare Technology Report published the list of The Top 50 Women Leaders in Healthcare Technology of 2024. Atropos Health’s Joy Somogyi, Senior Vice President, Marketing, has been named to The Healthcare Technology Report’s Top 50 Women...
« Older Entries
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Technology

Platform

GENEVA OS®

Evidence Generation Tools

ChatRWD®

Green Button®

Alexandria®

Forge®

Atropos Evidence™ Agent

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2025 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}